HP Showcases Life Sciences Contributions to Genetic Research & Drug Discovery

The solutions displayed include a representation of the more than 50 software applications available to genomics, bioinformatics, pharmaceutical, chemical and other life sciences companies, as well as to research institutions. Ranging in focus from research and development through clinical trials, the solutions support HP's strategy to become the life sciences industry's leading technical solutions partner. ``The life sciences industry needs fast workstations and servers, powerful systems and smart software to stay on the cutting edge,'' said David Valenta, global market development manager, HP Life Sciences. ``HP has become the partner of choice for many life sciences software developers and customers. These relationships help us closely track industry advances to enable HP's products and services to meet current and future needs.'' While other vendors seek entry points into this emerging industry, HP has been in the life sciences market since 1997 with solutions for computational chemists and molecular modelers. HP designs multi-purpose computers that can be configured to meet customers' specific needs and it provides a solid, scalable infrastructure with integrated solutions across hardware, software, servers, storage and networking. HP is demonstrating at BioITWorld the results of its work with industry leaders and pioneers to deliver solutions that enable biotechnology and pharmaceutical companies to accelerate drug research and bring significant discoveries to market quickly and cost-efficiently. Solutions on exhibit include offerings from: Viaken -- a provider of discovery solutions, integrated research informatics platforms and collaborative research services to the pharmaceutical, biotechnology, agrochemical and other life science industries; Genomix Corp. -- a provider of analysis systems, information resources and partnering opportunities to guide research and development teams through critical steps in the pharmaceutical discovery and development processes; and Illumitek -- whose flagship product, nViZn, is a development platform for building embedded or standalone visual intelligence applications. HP and illumitek recently announced plans to incorporate in HP OpenView Dynamic Netvalue Analyzer technology illumitek's D3 platform, an enabling technology that integrates robust data mining, analysis, visualization and Web-based interactivity into one development platform. HP is working to extend the Intel® Itanium(TM) Processor Family into the life sciences market to benefit customers with intensive data structures and computing needs. HP's Itanium-based systems are being engineered to run life sciences applications fast and reliably by providing a single, high-performance 64-bit architecture that can run on any of the three major operating systems: HP-UX, Linux and Microsoft® Windows®. HP also is providing demos of other HP products and services highlighting its comprehensive solutions, including HP Custom Software Solutions for security, porting and migration; RMSO, a business-to-employee portal solution that offers an interactive view of the @hp Employee portal; and its Federated Storage Area Management (FSAM) strategy, a scalable storage plan that will be useful to life sciences companies in breaking through storage bottlenecks in today's new pharmaceutical development phase.